CANX expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.478200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.164200E-01
Normal-vs-Stage2
6.476200E-01
Normal-vs-Stage3
3.466000E-01
Normal-vs-Stage4
4.673400E-01
Stage1-vs-Stage2
9.401200E-01
Stage1-vs-Stage3
1.633690E-02
Stage1-vs-Stage4
5.622800E-01
Stage2-vs-Stage3
9.876400E-02
Stage2-vs-Stage4
5.944000E-01
Stage3-vs-Stage4
6.572300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.582200E-01
Normal-vs-AfricanAmerican
3.913800E-01
Normal-vs-Asian
9.500000E-01
Caucasian-vs-AfricanAmerican
4.521400E-01
Caucasian-vs-Asian
3.370000E-01
AfricanAmerican-vs-Asian
2.430800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.095200E-01
Normal-vs-Female
7.003800E-01
Male-vs-Female
4.506400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.794400E-01
Normal-vs-Age(41-60Yrs)
2.700400E-01
Normal-vs-Age(61-80Yrs)
8.557000E-01
Normal-vs-Age(81-100Yrs)
9.943400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.98400000159549E-08
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.939100E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.197200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.584100E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.305600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.117200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.773200E-01
Normal-vs-Daily Drinker
8.893000E-01
Normal-vs-Weekly Drinker
9.683800E-01
Normal-vs-Occasional Drinker
3.826000E-01
Normal-vs-Social Drinker
5.544000E-01
Non Drinker-vs-Daily Drinker
7.621200E-01
Non Drinker-vs-Weekly Drinker
9.592800E-01
Non Drinker-vs-Occasional Drinker
4.919600E-02
Non Drinker-vs-Social Drinker
2.107000E-01
Daily Drinker-vs-Weekly Drinker
8.673000E-01
Daily Drinker-vs-Occasional Drinker
8.978000E-02
Daily Drinker-vs-Social Drinker
4.632400E-01
Weekly Drinker-vs-Occasional Drinker
1.195800E-01
Weekly Drinker-vs-Social Drinker
4.163400E-01
Occasional Drinker-vs-Social Drinker
3.051200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.520400E-01
Normal-vs-Grade 2
1.180770E-01
Normal-vs-Grade 3
9.421500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.999000E-01
Grade 1-vs-Grade 3
6.989000E-01
Grade 1-vs-Grade 4
2.520400E-01
Grade 2-vs-Grade 3
5.669000E-01
Grade 2-vs-Grade 4
1.180770E-01
Grade 3-vs-Grade 4
9.421500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.402600E-01
Normal-vs-NonDiabetic
6.488000E-01
Diabetic-vs-NonDiabetic
4.643600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.812800E-01
Normal-vs-NoPancreatitis
6.651000E-01
Pancreatitis-vs-NoPancreatitis
4.267200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.039800E-01
Normal-vs-N1
6.339800E-01
N0-vs-N1
6.263600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.537800E-01
Normal-vs-TP53-NonMutant
5.614200E-01
TP53-Mutant-vs-TP53-NonMutant
2.424200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
